Skip to content

MeninGene Recall study, substudy of the MeninGene study

MeninGene Recall study, substudy of the MeninGene study - MeninGene Recall study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42352
Enrollment
300
Registered
2015-07-30
Start date
2015-10-08
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bacterial meningitis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult survivors of community acquired bacterial meningitis who: 1. Participated in the Dutch Bacterial Meningitis Study II or MeninGene study 2. Gave informed consent to be approached for new research projects;Control persons who: 1. Participated in the Dutch Bacterial Meningitis Study II or MeninGene study 2. Gave informed consent to be approached for new research projects

Exclusion criteria

Exclusion criteria: Patients en control persons who: Had a bacterial meningitis episode in the 6 months previous to participation

Design outcomes

Primary

MeasureTime frame
- Baseline activity of the immune system and activation of the immune system assessed by ex vivo stimulation experiments - Cognitive functioning

Secondary

MeasureTime frame
- Quality of life - Quality of sleep - Antibody titers

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)